NASDAQ:GH

Guardant Health jumps 25% in a week as Medicare test looms
····

Guardant Health jumps 25% in a week as Medicare test looms

Guardant Health shares closed at $118.95 Friday, up 25% for the week, after the FDA approved an expanded version of its Guardant360 Liquid CDx blood test. The stock surged 17.1% on May 20 following the approval. Nasdaq will remain closed through Memorial Day, with trading set to resume Tuesday. Guardant raised its 2026 revenue outlook to $1.30–$1.32 billion after reporting a 48% jump in first-quarter revenue.
May 24, 2026

Stock Market Today

  • CBA vs Macquarie Shares: Choosing the Best ASX Financial Stock
    May 29, 2026, 8:54 PM EDT. Commonwealth Bank of Australia (CBA) and Macquarie Group Ltd (MQG) are two top ASX financial shares with distinct investment profiles. CBA offers stability, scale, and fully franked dividends, benefiting from its dominant position in Australian banking. It appeals to those seeking dependable income and resilience. However, CBA trades at a premium, reflecting its quality. Meanwhile, Macquarie is a global diversified financial group with interests in asset management, infrastructure, commodities, and energy transition. Its earnings are more variable, influenced by market conditions and deal flow, but it offers greater long-term growth potential by adapting to evolving global trends. Investors must weigh CBA's consistent returns against Macquarie's growth flexibility in today's market.